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In this issueofNeuron, Henandcolleaguesshednew lighton thebehavioral effectsoffluoxetine, oneof themost
commonlyprescribedantidepressants.This reportpromptsus to revisitourunderstandingof theneuralcircuitry
mediating mood disorders and also provides a framework for developing new antidepressant treatments.‘‘I’m like some king in whose cor-
rupted veins
Flows aged blood; who rules
a land of rains;
Who, young in years, is old in all
distress;
Who flees good counsel to find
weariness.’’
— Charles Baudelaire (1821–
1867), Spleen
Two conflicting views of mental illness
prevailed in the first half of the nineteenth
century. The so-called ‘‘Moral theorists’’
looked upon mental illness as an affliction
of themind that could be treatedwith kind-
ness and through appeal to the intellect.
Proponents of this school of thought
emphasized spiritual causes in their treat-
ment of madness. Other physicians
thought that a defective brain was the
culprit ofmental illness.Dubbed the ‘‘phys-
icalists,’’ these doctors attempted to treat
their patients by applying the most current
knowledge of brain research. Inspired by
the physicalist tradition, David et al. (2009)
conduct a study that sheds new light on
the nature of the disrupted circuits in
a model of depression, as well as the
numerous mechanisms by which antide-
pressants can correct these deficits.
Affective disorders, including ailments
such as depression and anxiety, are
among the most prevalent of all mental
health diagnoses. Depression or anxiety
can severely disrupt life by affecting appe-
tite, sleep, work, and social relationships.
Selective Serotonin Reuptake Inhibitors
(SSRIs), like fluoxetine, are the most
commonly prescribed drugs for such
mood disorders. However, very little is
known regarding the molecular mecha-nisms and the specific neural circuits
that underlie these drugs’ effects.
As antidepressants have established
themselves as the predominant treatment
for major depressive disorders, the devel-
opment of new treatments is never-
ending. In the process, animal models of
anxiety/depression are commonly used
to screen novel compounds for antide-
pressant properties, although the clinical
relevance and efficiency of such models
is debatable. For example, the behavior
produced by unpredictable chronic mild
stress in animals (Heine et al., 2004),
though widely used, is difficult to consis-
tently replicate. Alternatively, mice may
be supplied with exogenous corticoste-
rone (Gourley et al., 2008), a hormone
produced in the adrenal gland in response
to stress. Chronically elevated glucocorti-
coid levels are found in several commonly
used animal models of depression, in-
cluding restraint stress or forced swim-
ming. There is also evidence from human
studies that depression is oftenassociated
with dysfunctions of the hypothalamic-
pituitary-adrenal axis (Holsboer, 2008).
In a study detailed in this issue of
Neuron, David et al. (2009) utilize chronic
corticosterone treatment to develop a
mouse model exhibiting hallmark char-
acteristics of anxiety and depression.
They find that chronic fluoxetine treat-
ment reverses the behavioral deficits
induced by chronic corticosterone. Addi-
tionally, they investigate a possible link
between affective state disorders in this
model and hippocampal neurogenesis.
While the effect of fluoxetine on Novelty
Suppressed Feeding is neurogenesis
dependent (i.e., blocked by X-irradiation),
SSRI effects on Open Field and ForcedNeuSwim Test are neurogenesis independent
(Figure 1). Importantly, antidepressants
are effective only in the corticosterone-
treated animals.
A key question is whether studying the
effects of fluoxetine on corticosterone-
treated mice is relevant to the antidepres-
sant’s action in humans. Previously,
Tsankova et al. (2006) demonstrated that
both imipramine (a tricyclic antidepressant)
and fluoxetine can reverse social avoid-
ance inhumansaffectedwithdefeatstress,
butnot incontrol subjects. The ‘‘corticoste-
rone model’’ used by David et al. seems
to mimic these observations.
According to a recent theory, the failure
of adult hippocampal neurogenesis sets
the stage for the biological and cellular
basis of major depression (Sahay and
Hen, 2007). Approximately 9000 neurons
are produced daily in the dentate
gyrus (Cameron and McKay, 2001), and
reduced levels of neurogenesis could
lead to less adaptive behavior, which
may manifest itself through depressive
states marked with a helpless predisposi-
tion.Peoplediagnosedwithmajor depres-
sion presumably suffer from a deficit of
neurogenesis: they exhibit recollection-
memory deficits that are characteristic of
hippocampal damage, accompanied by
a reduction in hippocampal volume that
correlates with total illness duration (Mac-
Queen et al., 2003). However, the still
unresolved function of the adult-gener-
ated neurons (Lledo et al., 2006) is the
missing piece in this hypothesis.
It has been known for many years that
antidepressants increase hippocampal
neurogenesis (Malberg et al., 2000) and
that some of the behavioral effects of
antidepressant treatment require adultron 62, May 28, 2009 ª2009 Elsevier Inc. 453
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2003). However, in rodents
deprived of adult neurogene-
sis, some of the behavioral
effects of chronic antidepres-
sant treatment are still ob-
served. Also, transcranial
magnetic stimulation, another
effective treatment for de-
pression, does not stimulate
adult neurogenesis. It has
been suggested that drugs
with antidepressant activity
mediate their effects through
either neurogenesis-depen-
dent or neurogenesis-inde-
pendent mechanisms (Surget
et al., 2008). Here, David
et al. provide a significant
conceptual advance by de-
monstrating that the effects
of a single drug, fluoxetine,
are mediated through both
neurogenesis-dependent and
neurogenesis-independent
pathways, therefore recon-
ciling the initial discrepancies
(Figure 1).
Stimulation of adult neurogenesis in the
dentate gyrus is only one of several mech-
anisms through which antidepressants
exert their behavioral actions. Here, the
authors demonstrate that a chronic corti-
costerone regimen followed by fluoxetine
treatment affects gene expression not
only in the hippocampus, but also in the
hypothalamus and amygdala. Thus, the
neurogenesis-independent pathwaymight
be linked to signaling changes in these
other brain areas. The authors show that
only three genes, all related to G protein-
coupled receptors (b-arrestin 1, b-arrestin
2, and Gia2 proteins), have decreased
expression in the hypothalamus of de-
pressed animals. These reduced levels
are reversed by fluoxetine treatment.
Furthermore, genetic ablation of b-arrestin
2 blocked several of the behavioral effects
of fluoxetine, suggesting that b-arrestins
are essential mediators for the anxiolytic/
antidepressant activity of fluoxetine
(Figure 1). Previous results from Caron
and others had hinted that b-arrestin
2 KOmicemight exhibit an anxiety pheno-
type (Beaulieu et al., 2008), and b-arrestins
have been suggested to mediate the
effects of lithium, a drug commonly used
to treat bipolar disorder. The observation
that b-arrestin-2-deficient mice are unre-
sponsive to fluoxetine in most behavioral
tests (Figure1) raises thedistinctpossibility
that there are common mechanisms
underlying both bipolar disorder’s and
unipolar major depression’s response to
treatment, which may reflect the fact that
these disorders share common genetic
determinants such as a modulator of
glucocorticoid receptor sensitivity, FKBP5
(Willour et al., 2009). Altogether, the report
by David et al. contributes to erecting
a more unified theory of depression.
Are the therapeutic effects of fluoxetine
also dependent onmultiple distinct mech-
anisms? Might antidepressants work
through a combination of effects on both
cognitive functions and affect? Would
this result in a distinction between the
antidepressant-induced effects on the
hippocampus and those in other limbic
structures? It has been suggested that
the effects of antidepressants on mood
may be neurogenesis independent while
those on anxiety may be neurogenesis
dependent (Bessa et al., 2009). This is
an important question and suggests that
drug developers need to determine
whether compounds that directly stimulate
neurogenesiswould be effective as antide-
pressants or whether they
would only ameliorate cogni-
tive deficits.
Although unraveling the
pathophysiology of depres-
sion is a unique challenge, it
is by no means a new one.
Hippocrates described the
clinical presentation of de-
pression in the fourth century
B.C., attributing the ailment
to excessive amounts black
bile, or ‘‘melan chole’’ (from
which the word ‘‘melancholy’’
was coined). Ever since the
ancient Greek physicians, we
have made substantial prog-
ress in bringing to light the
complex brain mechanisms
involved in affective disor-
ders, particularly in decipher-
ing the molecular biology of
depression (Krishnan and
Nestler, 2008). Despite these
efforts, enormous gaps in the
knowledge of mood disorders
and their treatments remain.
While the report from David
et al. provides valuable insights with major
breakthroughs, it raises more questions
than it answers.What exactly can research
on rodent behavior tell us about human
psychopathology? Human psychiatric
disorders are complicated amalgams of
cognitive, affective, and behavioral abnor-
malities.Wemaybeable tomodel features
of one of these dimensions in rodents
(such as helplessness or anhedonia), but
we should be fully aware that we are only
studying an aspect of the disorder, not
the disorder itself per se.Major depressive
disorder in humans is certainly more than
the sum of its observable parts. Also,
how adult hippocampal neurogenesis
contributes to the regulation of affect is still
an open question. More work is necessary
to understand the link between adult
hippocampal neurogenesis and the action
of some antidepressant drugs. Thus far,
wehave littlemore thanphenomenological
reports. In order to address these ques-
tions, novel animal models need to be
developed that incorporate the powerful
array of molecular and anatomical tools
available today,whileemployingasystems
approach to reflect the powerful bidirec-
tional interactions between peripheral
organs and the brain. There is no doubt
Figure 1. Chronic Fluoxetine Reversed the Behavioral and
Neurogenic Deficits Induced by Chronic Corticosterone, Showing
Neurogenesis-Dependent and Neurogenesis-Independent Effects
NSF, Novelty Suppressed Feeding test; OF, Open Field.454 Neuron 62, May 28, 2009 ª2009 Elsevier Inc.
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Previewsthat Hen and colleagues have provided us
with a renewed impetus for this quest.
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